Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma
Y. Gao, M. Wang, X. Guo, J. Hu, T.-m. Chen, S. Finn, J. Lacy, J. Kunstman, C. Cha, M. Bellin, M. Robert, G. Desir, F. S. Gorelick
This study identifies renalase (RNLS) as a biomarker in pancreatic ductal adenocarcinoma (PDAC), showing elevated tissue and plasma levels correlate with worse tumor characteristics and reduced survival.
bioRxiv · Apr 12, 2021Cancer Biology